Endpoints NewsMore than 2000 drugs now in cancer immunotherapy raceReuters“The field is very promising and has the potential to deliver many breakthroughs to change the standard of care of many cancer types,” Shalabi and colleagues wrote in the journal… Continue reading
Endpoints NewsMore than 2000 drugs now in cancer immunotherapy raceReuters“The field is very promising and has the potential to deliver many breakthroughs to change the standard of care of many cancer types,” Shalabi and colleagues wrote in the journal… Continue reading
Daily IlliniUI scientists create drug-delivering nanoparticles to target cancer stem cellsDaily IlliniThe University is making major strides in stem cell cancer research, aiming to change the way various types of cancers are treated, as detailed in a r… Continue reading
FierceBiotechJuno strikes 3 deals to advance multiple myeloma combo treatmentFierceBiotechThe deals, signed with Eli Lilly, OncoTracker and Fred Hutchinson Cancer Research Center, aim to boost the development of a multiple myeloma therapy combining … Continue reading
FierceBiotech1-year data set Spark/Pfizer on track with hemophilia B gene therapy …FierceBiotechPatients with hemophilia B have seen their symptoms controlled for up to a year with a single dose of a gene therapy developed by Spark Therapeutics, almo… Continue reading
Ibrutinib More Effective Than Stem-Cell Transplant in Patients With Form of Chronic LeukemiaAJMC.com Managed Markets NetworkAn analysis presented at the 59th Annual Meeting of the American Society of Hematology showed that against a 3-year horizon, ibr… Continue reading
Endpoints News |
Taking on gamma delta T cells, bluebird pays $16M for TC BioPharm’s tumor invading tech platform
Endpoints News Gene therapy pioneer bluebird bio is teaming up with Scotland’s TC BioPharm to get its hands on an experimental program involving an emerging immunotherapy platform: CAR-engineered gamma delta T cells. As part of the deal, bluebird $BLUE is paying TC … bluebird bio (BLUE) Reports Strategic Collaboration with TC BioPharm to Research and Develop Gamma Delta CAR T …StreetInsider.com Life sciences group TC BioPharm secures $16m US tie-up to develop new cancer treatmentsinsider.co.uk TC BioPharm teams up with bluebird bio to develop gamma delta CAR TsSeeking Alpha NB Herard –Market Exclusive all 5 news articles » |